NCT07225621 2026-03-19
Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma
Alpheus Medical, Inc.
Phase 2 Recruiting
Alpheus Medical, Inc.
Mayo Clinic
Hemerion Therapeutics
Dartmouth-Hitchcock Medical Center
Medical College of Wisconsin
Universität Münster